New drug could cut IV nutrition needs for short bowel patients
NCT ID NCT06973304
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 3 trial tests a drug called teduglutide in 13 Chinese adults with short bowel syndrome who rely on IV nutrition. Participants get a daily injection for 24 weeks to see if it reduces their need for IV support. The study also checks safety and how the body processes the drug.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- teduglutide (a drug that helps the intestines absorb more nutrients)
- What this could lead to
- If it works, this could help people with short bowel syndrome reduce their dependence on intravenous nutrition, improving daily life.
- What could go wrong
- This is a small, early-phase trial with only 13 participants, so results may not apply to everyone. The drug may not work as hoped, and side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHORT BOWEL SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Affiliated Jinling Hospital, Medical School of Nanjing University
RECRUITINGNanjing, Jiangsu, 210016, China
-
Beijing Tsinghua Changgung Hospital
RECRUITINGChangping, Beijing Municipality, 102218, China
-
Peking Union Medical College Hospital
RECRUITINGDongcheng, Beijing Municipality, 100730, China
-
Zhongshan Hospital, Xiamen University
COMPLETEDSiming, Xiamen, 361004, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Measuring hidden energy needs: a clue to better nutrition for gut failure patients
- Weekly shot could help people with short bowel syndrome absorb more fluids
- Could a Plant-Based powder cut the need for IV nutrition?
- Growth hormone shows promise for weaning kids off IV nutrition
- New drug teduglutide monitored in 250 patients with short bowel syndrome
- New shot could cut IV feeding for short bowel patients